Search Results

Changes in the physical characteristics of the hyaluronate of ground substance with alterations in sodium chloride concentration.

• Authors : BLUMBERG BS; OSTER G; MEYER K

Subjects: Extracellular Matrix* ; Glycosaminoglycans*; Hyaluronic Acid/Hyaluronic Acid/Hyaluronic Acid/*metabolism

• Source: The Journal of clinical investigation [J Clin Invest] 1955 Sep; Vol. 34 (9), pp. 1454-61.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

Hyaluronate in normal human synovial fluid.

• Authors : HAMERMAN D; SCHUSTER H

Subjects: Glycosaminoglycans* ; Synovial Fluid*; Hyaluronic Acid/Hyaluronic Acid/Hyaluronic Acid/*metabolism

• Source: The Journal of clinical investigation [J Clin Invest] 1958 Jan; Vol. 37 (1), pp. 57-64.Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model:

Record details

An osteopontin/CD44 immune checkpoint controls [CD8.sup.+] T cell activation and tumor immune evasion.

• Authors : Klement, John D.; Paschall, Amy V.; Redd, Priscilla S.

• Source: Journal of Clinical Investigation. December, 2018, Vol. 128 Issue 12, p5549, 12 p.

Record details

Osteopontin controls immunosuppression in the tumor microenvironment.

• Authors : Shurin, Michael R.

• Source: Journal of Clinical Investigation. December, 2018, Vol. 128 Issue 12, p5209, 4 p.

Record details